Iterum Therapeutics Plc (ITRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Operating Expenses | 6,335 | 8,253 | 12,894 | 23,178 | 30,999 |
| Operating Income | -6,335 | -8,253 | -12,894 | -23,178 | -30,999 |
| Interest Expense | 4,183 | 4,075 | 2,596 | 406 | 216 |
| Other Income | -1,261 | -15 | -489 | -8 | 48 |
| Pre-tax Income | -11,779 | -12,343 | -15,979 | -23,592 | -31,167 |
| Income Tax | 420 | 178 | 121 | 49 | 104 |
| Net Income Continuous | -12,199 | -12,521 | -16,100 | -23,641 | -31,271 |
| Net Income | $-12,199 | $-12,521 | $-16,100 | $-23,641 | $-31,271 |
| EPS Basic Total Ops | -9.00 | -11.99 | -16.19 | -23.69 | -32.23 |
| EPS Basic Continuous Ops | -8.97 | -12.02 | -16.23 | -23.84 | -32.18 |
| EPS Diluted Total Ops | -9.00 | -11.99 | -16.19 | -23.69 | -32.23 |
| EPS Diluted Continuous Ops | -8.97 | -12.02 | -16.23 | -23.84 | -32.18 |
| EBITDA(a) | $-3,193 | $-5,108 | $-11,241 | $-23,020 | $-30,887 |